Key facts
- This page summarizes Patrick G. Enright's Form 4 filing for Veradermics, Inc (MANE).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 05 Feb 2026, 19:03.
Patrick G. Enright - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- MANE
- Reported as of
- 03 Feb 2026
- Net transaction value
- +$18,275,000
- SEC form
- 4
- Accepted by SEC
- 05 Feb 2026, 19:03:06 UTC
- Prior SEC filing
- 15 Dec 2025
- Next SEC filing
- 26 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Greco, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick G. Enright filed Form 4 for Veradermics, Inc (MANE) on 05 Feb 2026.
Change
- Previous filing in this sequence was filed on 15 Dec 2025.
- Current net transaction value: +$18,275,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001253886
Primary reporting owner
ENRIGHT PATRICK G
- Relationship
- Director, 10%+ Owner
- Address
- C/O LONGITUDE CAPITAL, 2740 SAND HILL ROAD, SECOND FLOOR, MENLO PARK
- Signature
- /s/ Michael Greco, Attorney-in-Fact
- Signature date
- 05 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MANE
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,236,631
- Change %
- Price
- Shares after
- 1,236,631
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F1, F2
MANE
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,171,121
- Change %
- +95%
- Price
- Shares after
- 2,407,752
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F2, F3
MANE
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,171,121
- Change %
- Price
- Shares after
- 1,171,121
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F3, F4
MANE
transaction
Common Stock
Purchase
- Transaction value
- $3,274,999
- Shares
- +192,647
- Change %
- +8%
- Price
- $17.00
- Shares after
- 2,600,399
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F2
MANE
transaction
Common Stock
Purchase
- Transaction value
- $15,000,001
- Shares
- +882,353
- Change %
- +75%
- Price
- $17.00
- Shares after
- 2,053,474
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MANE
transaction
Derivative
Series B Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,236,631
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 1,236,631
- Exercise price
- Footnotes
- F1
MANE
transaction
Derivative
Series C Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,171,121
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 1,171,121
- Exercise price
- Footnotes
- F3
MANE
transaction
Derivative
Series C Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,171,121
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 1,171,121
- Exercise price
- Footnotes
- F3
MANE
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +45,131
- Change %
- Price
- $0.000000
- Shares after
- 45,131
- Date
- 03 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 45,131
- Exercise price
- $17.00
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
Footnote F2
These shares are held by Longitude Venture Partners V, L.P. ("LVPV"). Longitude Capital Partners V, LLC ("LCPV"), is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of LCPV, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of LCPV, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
Footnote F3
On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
Footnote F4
These shares are held by Longitude 103.8 East, L.P. ("L103"). Longitude 103.8 East Partners, LLC ("L103P") is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of L103P, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of L103P, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
Footnote F5
This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.